These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 6989195)

  • 21. [Results of treating obliterative diseases of the peripheral arteries with intra-arterial administrations of acetylcholine].
    Stepanova-Nikitina GG; Rage KM
    Sov Med; 1970; 33(8):45-9. PubMed ID: 5490077
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of a new sympatholytic drug in therapy of chronic peripheral obliterating artery diseases].
    Vittori C; Taborelli G; Taborelli R
    Minerva Cardioangiol; 1965 Sep; 13(9):585-91. PubMed ID: 5851172
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic acquisitions on chronic obliterating peripheral arterial diseases of the lower limbs].
    Guagliano G; Bagliani A; Borri P
    Minerva Med; 1976 May; 67(25):1648-55. PubMed ID: 778666
    [No Abstract]   [Full Text] [Related]  

  • 24. Levodopa in the treatment of arterial insufficiency of the lower limbs. Clinical and rheographic trial.
    Vaccaro E; Solitro A; Barba C
    Arzneimittelforschung; 1973 Dec; 23(12):1793-8. PubMed ID: 4205907
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical studies on the vasodilating and anti-platelet effects of OP-41483, a prostacyclin derivative.
    Kusaba A; Shiroma H; Shrestha DR; Koja K; Kina M; Kuniyoshi Y; Iha K; Kinjo O; Akasaki M; Kugai T
    Jpn J Surg; 1991 Jan; 21(1):8-13. PubMed ID: 2041246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of peripheral ischemizing arteriopathies with diisopropylammonium dichloroethanoate (Diedì), a drug with action prevalent on respiratory tissue metabolism].
    Maggi GC; Tartara A
    Minerva Cardioangiol; 1965 Jul; 13(7):382-3. PubMed ID: 5838538
    [No Abstract]   [Full Text] [Related]  

  • 27. [Mydocalm administered in electrophoresis].
    Chmielewski F
    Pol Tyg Lek; 1971 Jul; 26(30):1170-2. PubMed ID: 5092988
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of prostacyclin (PGI2) on retinal arteries].
    Zygulska-Machowa H; Kostka-Trabkowa E; Nitoń A; Dembińska-Kieciowa A; Kedzior A; Basista M; Gryglewski RJ
    Klin Oczna; 1984 Apr; 86(4):149-51. PubMed ID: 6381868
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of bencyclane in obliterative arterial diseases].
    Kusztos D
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1419+. PubMed ID: 5536658
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical considerations and functional data on the use of the association of kallikrein and meso-inositol hexanicotinate in the therapy of obliterating arteriopathy].
    Blasi A; Licciardello M
    Clin Ter; 1966 Jul; 38(2):121-58. PubMed ID: 5990194
    [No Abstract]   [Full Text] [Related]  

  • 31. [Taurine in the therapy of obliterating arteriopathy of the lower extremities. I. Clinical results in various evolutive phases].
    Zanelli G; Ferrero S; Patrone P
    Minerva Cardioangiol; 1971 Nov; 19(11):605-15. PubMed ID: 5128422
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy].
    Cascio F
    Minerva Cardioangiol; 1973 Nov; 21(11):715-31. PubMed ID: 4776567
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prostacyclin therapy of peripheral artery disease].
    Kusaba A
    Kokyu To Junkan; 1985 Jul; 33(7):871-6. PubMed ID: 3903902
    [No Abstract]   [Full Text] [Related]  

  • 34. The significance of vasodilator therapy in obliterative arterial disease.
    Thulesius O
    Scand J Clin Lab Invest Suppl; 1967; 99():222-4. PubMed ID: 6056925
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experiences with the treatment of peripheral vascular diseases with Xavin].
    Brücknerová O
    Vnitr Lek; 1973 Apr; 19(4):379-86. PubMed ID: 4699159
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of phenformin and stanozol administration on lipid metabolism in patients with occlusive vascular diseases].
    Perzanowski A; Bielawiec M; Myśliwiec M
    Pol Tyg Lek; 1972 Jan; 27(5):174-6. PubMed ID: 5010762
    [No Abstract]   [Full Text] [Related]  

  • 37. Pyridinolcarbamate, bradykinin antagonist, in patients suffering from arteriosclerosis obliterans and thromboangiitis obliterans (Buerger's disease); a preliminary report on the treatment of human atherosclerosis.
    Shimamoto T; Atsumi T
    Jpn Heart J; 1965 Sep; 6(5):407-15. PubMed ID: 5294603
    [No Abstract]   [Full Text] [Related]  

  • 38. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease].
    Seghezzi R; Pedroni G; Borri P
    Chir Ital; 1967; 19():Suppl 2:222+. PubMed ID: 5190600
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypervolemic treatment of the chronic obliterative arteriopathies of extremities.
    Brassai Z; Koválszki P; Pop GH; Kiss K; Olosz E
    Med Interne; 1986; 24(1):37-41. PubMed ID: 2422732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of prostacyclin on glycemia and insulin release in man.
    Szczeklik A; Pietoń R; Sieradzki J; Nizankowski R
    Prostaglandins; 1980 Jun; 19(6):959-68. PubMed ID: 6104347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.